National medical group appoints two executives

GenesisCare has also committed more than $300 million to upgrade technology and cancer treatment services nationwide.

  • By Business Observer Staff
  • | 8:07 a.m. June 22, 2021
  • | 0 Free Articles Remaining!
Courtesy. Dr. Bridget Koontz was named U.S. Chief Medical Officer and Deputy Group CMO at GenesisCare.
Courtesy. Dr. Bridget Koontz was named U.S. Chief Medical Officer and Deputy Group CMO at GenesisCare.
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Australian cancer treatment giant GenesisCare, which entered the U.S. in late 2019 when it acquired Fort Myers-based 21st Century Oncology, has named two top domestic medical officials.

The Sydney, Australia-based firm named Dr. Bridget Koontz U.S. Chief Medical Officer and Deputy Group CMO and Dr. Neal Shore U.S. Chief Medical Officer of Surgery and Urology.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • December 15, 2025
Lee Health CEO to step down
  • December 15, 2025
Credit union names market president for three counties in region
  • December 15, 2025
3 Polk County residents charged in $2M COVID fraud case
  • December 15, 2025
Pinellas artwork manufacturer completes $13.5M facility expansion

Sponsored Content